Galectin-3, Recombinant, Human (IgE-Binding Protein, Gal-3, 35kD Lectin, Carbohydrate-Binding Protein 35, CBP 35, Galactose-Specific Lectin 3, Galactoside-Binding Protein, GALBP, L-31, Laminin-Binding Protein, Lectin L-29, Mac-2 Antigen, LGALS3)

Catalog No : USB-500032
491.97€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Galectin-3, Recombinant, Human (IgE-Binding Protein, Gal-3, 35kD Lectin, Carbohydrate-Binding Protein 35, CBP 35, Galactose-Specific Lectin 3, Galactoside-Binding Protein, GALBP, L-31, Laminin-Binding Protein, Lectin L-29, Mac-2 Antigen, LGALS3)
Catalog No USB-500032
Supplier’s Catalog No 500032
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 26.1
Storage -20°C
Other names
Grade Highly Purified
Purity ~95% (SDS-PAGE)
Form Supplied as a lyophilized powder in PBS, 2-ME, BSA. Reconstitute with sterile PBS to 0.5mg/ml.
Reactivity life 6 months
Note For reserch purpose only
Purity ~95% (SDS-PAGE)
Description Gal-3 interacts, via its lectin domain, with glycoproteins and glycolipids on the surface of animal cells. It has been shown that nuclear Gal­3 can modulate gene expression while cytosolic Gal­3 can inhibit apoptosis and participate in exocytosis. Gal-3 is generally expressed by the epithelial cells of many tissues as well as by inflammatory cells. An increased level of Gal-3 expression may lead to some lymphomas, as well as thyroid and hepatic carcinomas while the down-regulation has been associated with breast and colon cancer. Source: Recombinant protein corresponding to human Galectin-3 expressed in E. coli. Molecular Weight: ~26.1kD Biological Activity: Measured by its ability to agglutinate human red blood cells. The ED50 for this effect is typically 3-10ug/mL. Endotoxin: <1EU/ug (LAL) Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.